Abstract:Clinical studies have found 14-3-3η to be associated with osteoporosis through undefined mechanisms. We aimed to investigate the role of 14-3-3η in osteoporosis and its potential associations with miRNAs. The Gene Expression Omnibus(GEO) and Human Protein Atlas 1 databases were analyzed to examine both the mRNA and protein expression of 14-3-3η in OP. Gene enrichment analyses were performed to explore the underlying mechanism of 14-3-3η based on DAVID. miRWalk was used to predict the associated miRNAs. The statistics were analysed by R software and SPSS software. 14-3-3η was overexpressed and knock down expressed in BMSCs by lentiviral vector transfecting. And BMSCs were induced by hypoxia. qRT-PCR and Western-Blot verified the expression of mRNA and protein. Scratch assay detected the migration of osteocytes. Co-immunoprecipitation and luciferase assay studied the 14-3-3η targeted protein and miRNA. overexpression and knock down of miRNA to verify the relationship of 14-3-3η and target genes. The 14-3-3η mRNA expression level was low in patients with osteoporosis, as corroborated by immunohistochemical staining images. Functional analyses revealed enrichment of the MAPK-associated cascade. 14-3-3η was correlated with MAPK family proteins and five key miRNAs, including mir-142-3p. In addition, 14-3-3η knockdown in BMSCs increased the mRNA and protein expression levels of Hif-α, VEGF, BMP-2, OPN, OST, and Runx2, and enhanced the cells migration ability. Under hypoxic conditions, Hif-α and BMP-2 protein expression levels were upregulated, whereas those of 14-3-3η and MAPK3 were downregulated. Co-immunoprecipitation experiments showed decreased binding of 14-3-3η to MAPK3. 14-3-3η knockdown produced the same results as hypoxia induction. Adding caspase3 inhibitor and knocking down 14-3-3η again prevented MAPK3 cleavage by caspase3 and inhibited BMP-2 expression. Moreover, under hypoxic conditions, miR-142-3P expression was upregulated and luciferase assays revealed 14-3-3η as its target gene. miR-142-3P overexpression decreased mRNA and protein levels of 14-3-3η and MAPK3, while increasing BMP-2 expression. miR-142-3P knockdown reversed these results. BMSC osteogenesis was suppressed by 14-3-3η , whereas miRNA-142-3p promoted it through the inhibition of 14-3-3η .

Silencing of Mir-330-5p Stimulates Osteogenesis in Bone Marrow Mesenchymal Stem Cells and Inhibits Bone Loss in Osteoporosis by Activating Bgn-mediated BMP/Smad Pathway.

Mmu-miR-185 Depletion Promotes Osteogenic Differentiation and Suppresses Bone Loss in Osteoporosis Through the Bgn-mediated BMP/Smad Pathway

Silencing Mir-106 B Accelerates Osteogenesis of Mesenchymal Stem Cells and Rescues Against Glucocorticoid-Induced Osteoporosis by Targeting BMP 2

MiR-486-3p promotes osteogenic differentiation of BMSCs by targeting CTNNBIP1 and activating Wnt/β-catenin pathway

Overexpression of miR-195-5p reduces osteoporosis through activating BMP-2/SMAD/Akt/RUNX2 pathway via targeting SMURF1.

MiR-486–3p promotes osteogenic differentiation of BMSC by targeting CTNNBIP1 and activating the Wnt/β-catenin pathway

Mir-664-3p Suppresses Osteoblast Differentiation And Impairs Bone Formation Via Targeting Smad4 And Osterix

The Mir-1906 Mimic Attenuates Bone Loss in Osteoporosis by Down-Regulating the TLR4/MyD88/NF‐κB Pathway

Overexpressed miR‐196a accelerates osteogenic differentiation in osteoporotic mice via GNAS‐dependent Hedgehog signaling pathway

Osteoblast-targeted Delivery of Mir-33-5p Attenuates Osteopenia Development Induced by Mechanical Unloading in Mice.

METTL3-mediated LINC00657 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Via Mir-144-3p/bmpr1b Axis

Mir-30 Family Members Negatively Regulate Osteoblast Differentiation*

The Regulatory Effect of Mir-181c-5p On the Differentiation Function of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporotic Mice

Mir-381-3p aggravates ovariectomy-induced osteoporosis by inhibiting osteogenic differentiation through targeting KLF5/Wnt/β-catenin signaling pathway

Inhibition of miR-200c Expression Promotes Activation of Extracellular Signal-Regulated Kinase (ERK)/ Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway and Inhibits Osteogenic Differentiation in Osteoporosis Mice

Mir-204 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells by Targeting Bone Morphogenetic Protein 2

Biological Role of miRNA-302a-3p/DKK1 in Osteogenesis of Bone-Marrow Derived Mesenchymal Stem Cells

Mir-214 Suppresses the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and These Effects Are Mediated Through the Inhibition of the JNK and P38 Pathways.

Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis

Microrna-338-3p Regulates Osteogenic Differentiation of Mouse Bone Marrow Stromal Stem Cells by Targeting Runx2 and Fgfr2

TGF-(31-triggered (3 1-Triggered BMI1 and SMAD2 Cooperatively Regulate Mir-191 to Modulate Bone Formation